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tate this. Only 14% would have considered neoadjuvant chemotherapy
with the same aim. Despite our BCS patients having to travel a consider-
able distance daily for radiotherapy, only 4% found it problematic. Eighty-
eight percent of patients who had BCS were happy with their treatment
decision, 72% being happy with the cosmetic outcome.
Conclusion: BCS is something that patients aged 70+ are interested in
considering. More than a third of mastectomy patients would be willing to
take neoadjuvant endocrine therapy to facilitate BCS.
0266: BREAST CANCER PRESENTATION IN THE OVER 70S
L. Smith*, J. Murray, A. Lannigan. Wishaw General Hospital, UK
Aim: To explore the presentation of the over 70s with breast cancer, along
with attitudes towards screening.
Methods: A questionnaire was sent to patients aged 70+ at breast cancer
diagnosis in NHS Lanarkshire between 2006 and 2013. This detailed rea-
sons and timing of presentation, in addition to thoughts about screening.
Results: Three hundred and ﬁfty-two questionnaires were sent with a 65%
response rate.
Sixty-four percent routinely examined themselves with 70% identifying a
lump themselves. Distressingly only 36% were aware of the other signs/
symptoms of breast cancer.
The majority of women sought medical attention early, with 39% pre-
senting within days, personal concern was the greatest prompt (68%).
Eighty-three percent routinely attended screening when invited, a further
3% willing to attend once over 70. The majority (60%) were not aware that
they could opt into the screening service when over 70.
Conclusion: Despite the belief that older women are less breast aware
most of our patients routinely examined themselves, identiﬁed pathology,
and promptly sought medical advice. Despite most women having no
knowledge of other signs and symptoms of breast cancer. Our cohort has
also shown that they are keen to continue screening over the age of 70 if it
was routinely offered.
0278: EVALUATING THE QUALITY OF INTERNET INFORMATION FOR
BREAST CANCER
A. Nghiem*, Y. Mahmoud, R. Som. Lewisham and Greenwich NHS Trust, UK
Aim: The internet is frequently used by patients for researching infor-
mation regarding breast cancer. Though much of it is contemporaneous
and of good quality, a signiﬁcant proportion of this information is un-
regulated, and potentially misleading. This study aims to assess the
quality of information on the internet regarding breast cancer using
validated tools.
Methods: The term 'breast cancer' was searched for in 3 search engines.
The top 20 results were selected and after duplicates and irrelevant
websites were excluded, the remaining websites were analysed using the
DISCERN Plus tool, HONcode and the JAMA benchmarks.
Results: 26 unique websites were assessed. The average score using the
DISCERN criteria was 57 out of a possible total of 80 e classed as ‘good’
(range: 25e74). Charity websites had the highest average score; 63 e
classed ‘excellent’. 9 websites were found to be HONcode certiﬁed. 7
websites complied with all four JAMA benchmarks.
Conclusion: This study shows the quality of breast cancer information on
the internet is on the whole good; however the range of quality is wide.
Patients may be heavily reliant on information available on the internet so
it is important for healthcare professionals involved in breast cancer care
to understand the nature of this information.
0290: AXILLARY STAGING IN BREAST CANCER: IMPROVEMENTS IN PRE-
OPERATIVE ULTRASOUND EVALUATION AT MUSGROVE PARK HOSPITAL
H. Weaver*, A. Brown, N. Atherton, S. Rahma, J. Gill, A. Thorne. Musgrove
Park Hospital, UK
Aim: NICE Guidelines (2009) advise that pre-treatment ultrasound eval-
uation of the axilla is undertaken for patients with early, invasive breast
cancer, and that ultrasound-guided needle sampling of any abnormalnodes should be performed. Pre-operative assessment of the axilla has
been standard practice at this unit since 2010. Our aim was to establish
whether rates of pre-operative diagnosis of axillary metastases have
changed since then.
Methods: Data were collected on all axillary procedures performed in
breast cancer patients between April 2010 and February 2014 at a busy
district general hospital. Cases were identiﬁed using consultant databases,
histopathology records and theatre diaries. Patients receiving neo-adju-
vant chemotherapy were excluded.
Results: 987 cases were identiﬁed. 279 patients had malignancy in the
axilla and 101 of these were diagnosed pre-operatively. The proportion of
patients with axillary malignancy diagnosed pre-operatively, as opposed
to using sentinel node biopsy, has increased year on year (21% in 2010-11;
37% in 2011e12; 48% in 2012e13 and 51% in 2013-14).
Conclusion: Over time, there has been a signiﬁcant trend towards diag-
nosing axillary malignancy pre-operatively rather than intra-operatively
on sentinel node biopsy. This suggests a learning curve in the use of
axillary ultrasound and node sampling in the unit.
0416: A RETROSPECTIVE ANALYSIS OF SURVIVAL AFTER BREAST
CANCER RECURRENCE: EVALUATION OF PREDICTIVE
CLINICOPATHOLOGICAL VARIABLES AND TREATMENT EFFECT
Y.K. Foo*, J. Byrne, R. Dave, E. Scott, Z. Kryjak, D. Ali. Pinderﬁelds General
Hospital, UK
Aim: To evaluate predictive clinicopathological variables of survival
following breast cancer recurrence.
Methods: All coded recurrences from January 2009 to January 2014
resulting from breast cancer resections from January 1988 to January 2013
were included in our study. Of the 272 patients identiﬁed, data was
available for 257 patients, and the clinicopathological variables were
analysed. The median follow-up was 9.40 years (IQR; 6.10e14.56). Survival
following recurrence was then calculated using log rank test.
Results: Survival following breast cancer recurrence was not predicted by
grade (p¼0.233), size (<50mm vs 50mm, p¼0.234) and hormone re-
ceptor status (ER+ve vs ER-ve; p¼0.873 and Triple negative; p¼0.224) of
the original tumour. There was no difference in the disease-free survival
between patients who developed distant and locoregional recurrence,
however, the overall survival following distant metastasis was 33.3
months, and that for locoregional disease was 54.6 months (n¼229,
p¼0.000). The majority of patients with locoregional disease (50/83) had
surgical management, and these patients had signiﬁcantly better post-
recurrence median survival (62 months) than those who had either
cytotoxic chemotherapy (33 months) or anti-hormone therapy (41
months).
Conclusion: Clinicopathological variables of the primary tumour cannot
predict recurrence; however aggressive surgical management of locore-
gional recurrence will improve survival compared to systemic therapy.
0451: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE INCIDENCE
AND PREDICTORS OF BLOOD TRANSFUSION IN BREAST
RECONSTRUCTION POST TRAM (TRANSVERSE RECTUS ABDOMINUS
MYOCUTANEOUS) FLAP AND DIEP (DEEP INFERIOR EPIGASTRIC
PERFORATOR) FLAP
S. Sepehripour a, G. Filobbos a,*, C. Malata b. aUniversity Hospital Coventry
and Warwickshire, UK; bAddenbrooke Hospital, UK
Aim: Despite the increase in number of women opting to have autologous
breast reconstruction with TRAM or DIEP ﬂaps, there is paucity in litera-
ture regarding the incidence and predictors of blood transfusion associated
with these procedures. The aim of the study is to conduct a systematic
review and meta-analysis of the incidence and predictors of blood trans-
fusion post TRAM and DIEP ﬂaps. To the best of our knowledge, this is the
only systematic review in literature on this topic.
Methods: Literature search conducted on Pubmed, Ovid medline and
EMBASE databases. Statistical analysis investigating odds ratio of trans-
fusion and correlation.
Results: The search identiﬁed 11 studies and no clinical trials. The reported
rate of transfusion ranges from 9.1% to 80.3% for DIEP and around 9% For
